These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 27036379)

  • 1. Glucocorticoid Effect on Radiographic Progression in Placebo Arms of Rheumatoid Arthritis Biologics Trials.
    Boers M; Aletaha D; Mela CM; Baker DG; Smolen JS
    J Rheumatol; 2016 Jun; 43(6):1024-6. PubMed ID: 27036379
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Towards the Lowest Efficacious Dose: Results From a Multicenter Noninferiority Randomized Open-Label Controlled Trial Assessing Tocilizumab or Abatacept Injection Spacing in Rheumatoid Arthritis in Remission.
    Kedra J; Dieudé P; Giboin C; Marotte H; Salliot C; Schaeverbeke T; Perdriger A; Soubrier M; Morel J; Constantin A; Dernis E; Royant V; Salmon JH; Pham T; Gottenberg JE; Pertuiset E; Dougados M; Devauchelle-Pensec V; Gaudin P; Cormier G; Goupille P; Mariette X; Berenbaum F; Alcaix D; Rouidi SA; Berthelot JM; Monnier A; Piroth C; Lioté F; Goëb V; Gaujoux-Viala C; Chary-Valckenaere I; Hajage D; Tubach F; Fautrel B;
    Arthritis Rheumatol; 2024 Apr; 76(4):541-552. PubMed ID: 37942714
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized controlled trial design in rheumatoid arthritis: the past decade.
    Strand V; Sokolove J
    Arthritis Res Ther; 2009; 11(1):205. PubMed ID: 19232061
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Effect of Low-Dose Glucocorticoids Over Two Years on Weight and Blood Pressure in Rheumatoid Arthritis.
    Palmowski A; Boers M; Kirwan J; Christensen R; Buttgereit F
    Ann Intern Med; 2024 Apr; 177(4):546-547. PubMed ID: 38621267
    [No Abstract]   [Full Text] [Related]  

  • 5. The Effect of Low-Dose Glucocorticoids Over Two Years on Weight and Blood Pressure in Rheumatoid Arthritis.
    Theophilopoulos A; Bubb MR
    Ann Intern Med; 2024 Apr; 177(4):546. PubMed ID: 38621266
    [No Abstract]   [Full Text] [Related]  

  • 6. The Effect of Low-Dose Glucocorticoids Over Two Years on Weight and Blood Pressure in Rheumatoid Arthritis.
    Narula K; Lazarus K; Choudhury S; Meeran K
    Ann Intern Med; 2024 Apr; 177(4):545-546. PubMed ID: 38621265
    [No Abstract]   [Full Text] [Related]  

  • 7. The Effect of Low-Dose Glucocorticoids Over Two Years on Weight and Blood Pressure in Rheumatoid Arthritis.
    Arkfeld D; Gonzales SAB; Ruddy K
    Ann Intern Med; 2024 Apr; 177(4):545. PubMed ID: 38621264
    [No Abstract]   [Full Text] [Related]  

  • 8. Improvement in joint inflammation is accompanied by reduction in arterial inflammation: Tocilizumab in rheumatoid arthritis.
    Zureigat H; Civieri G; Abohashem S; Osborne MT; Solomon DH; Giles JT; Bathon J; Massarotti E; Unizony S; Tawakol A
    J Nucl Cardiol; 2024 Mar; 33():101813. PubMed ID: 38266667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Joint Damage Over Time in Patients With Early Rheumatoid Arthritis Follows Trajectories Related to Distinct Courses of Disease Activity.
    Dumoulin QA; Verstappen M; van der Helm-van Mil AHM; van Steenbergen HW
    J Rheumatol; 2023 Apr; 50(4):573-575. PubMed ID: 36319022
    [No Abstract]   [Full Text] [Related]  

  • 10. Methotrexate monotherapy and methotrexate combination therapy with traditional and biologic disease modifying antirheumatic drugs for rheumatoid arthritis: abridged Cochrane systematic review and network meta-analysis.
    Hazlewood GS; Barnabe C; Tomlinson G; Marshall D; Devoe D; Bombardier C
    BMJ; 2016 Apr; 353():i1777. PubMed ID: 27102806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-Term Outcomes of Patients With Recent-Onset Rheumatoid Arthritis After 10 Years of Tight Controlled Treatment: A Randomized Trial.
    Markusse IM; Akdemir G; Dirven L; Goekoop-Ruiterman YP; van Groenendael JH; Han KH; Molenaar TH; Le Cessie S; Lems WF; van der Lubbe PA; Kerstens PJ; Peeters AJ; Ronday HK; de Sonnaville PB; Speyer I; Stijnen T; Ten Wolde S; Huizinga TW; Allaart CF
    Ann Intern Med; 2016 Apr; 164(8):523-31. PubMed ID: 27089068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical efficacy and safety maintained up to 5 years in patients with rheumatoid arthritis treated with tocilizumab in a randomised trial.
    Kremer JM; Blanco R; Halland AM; Brzosko M; Burgos-Vargas R; Mela CM; Rowell L; Fleischmann RM
    Clin Exp Rheumatol; 2016; 34(4):625-33. PubMed ID: 27087059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adalimumab, etanercept, infliximab, certolizumab pegol, golimumab, tocilizumab and abatacept for the treatment of rheumatoid arthritis not previously treated with disease-modifying antirheumatic drugs and after the failure of conventional disease-modifying antirheumatic drugs only: systematic review and economic evaluation.
    Stevenson M; Archer R; Tosh J; Simpson E; Everson-Hock E; Stevens J; Hernandez-Alava M; Paisley S; Dickinson K; Scott D; Young A; Wailoo A
    Health Technol Assess; 2016 Apr; 20(35):1-610. PubMed ID: 27140438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brief Report: Risk of Gastrointestinal Perforation Among Rheumatoid Arthritis Patients Receiving Tofacitinib, Tocilizumab, or Other Biologic Treatments.
    Xie F; Yun H; Bernatsky S; Curtis JR
    Arthritis Rheumatol; 2016 Nov; 68(11):2612-2617. PubMed ID: 27213279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brief Report: A Prospective Open-Label Phase IIa Trial of Tocilizumab in the Treatment of Polymyalgia Rheumatica.
    Lally L; Forbess L; Hatzis C; Spiera R
    Arthritis Rheumatol; 2016 Oct; 68(10):2550-4. PubMed ID: 27159185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tapering biologic and conventional DMARD therapy in rheumatoid arthritis: current evidence and future directions.
    Schett G; Emery P; Tanaka Y; Burmester G; Pisetsky DS; Naredo E; Fautrel B; van Vollenhoven R
    Ann Rheum Dis; 2016 Aug; 75(8):1428-37. PubMed ID: 27261493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of disease activity with acute exacerbation of interstitial lung disease during tocilizumab treatment in patients with rheumatoid arthritis: a retrospective, case-control study.
    Akiyama M; Kaneko Y; Yamaoka K; Kondo H; Takeuchi T
    Rheumatol Int; 2016 Jun; 36(6):881-9. PubMed ID: 27072347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biologics or tofacitinib for rheumatoid arthritis in incomplete responders to methotrexate or other traditional disease-modifying anti-rheumatic drugs: a systematic review and network meta-analysis.
    Singh JA; Hossain A; Tanjong Ghogomu E; Kotb A; Christensen R; Mudano AS; Maxwell LJ; Shah NP; Tugwell P; Wells GA
    Cochrane Database Syst Rev; 2016 May; 2016(5):CD012183. PubMed ID: 27175934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vasculitis syndromes: Tocilizumab safe and effective for PMR.
    Shipman L
    Nat Rev Rheumatol; 2016 Jul; 12(7):374. PubMed ID: 27225306
    [No Abstract]   [Full Text] [Related]  

  • 20. Tocilizumab in Giant Cell Arteritis: A Multicenter Retrospective Study of 34 Patients.
    Régent A; Redeker S; Deroux A; Kieffer P; Ly KH; Dougados M; Liozon E; Larroche C; Guillevin L; Bouillet L; Espitia O; Costedoat-Chalumeau N; Soubrier M; Brihaye B; Lifermann F; Lefevre G; Puéchal X; Mouthon L; Toussirot E;
    J Rheumatol; 2016 Aug; 43(8):1547-52. PubMed ID: 27182063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.